Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Plos One
|
November 1, 2023
The inflammatory response of human pancreatic cancer samples compared to normal controls
Kathryn J Brayer, Joshua A Hanson, Shashank Cingam, et al.
Oncology Research
|
February 10, 2011
Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients
Hamid Sayar, Jeffrey T Bunning, Therese J Bocklage, et al.
American Journal of Clinical Oncology
|
November 4, 2009
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer
Houman M Fekrazad, Claire F Verschraegen, Melanie Royce, et al.
Plos One
|
March 18, 2016
Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells
Alexandra M Fajardo, Debra A MacKenzie, Sarah L Olguin, et al.
Urologic Oncology
|
March 28, 2008
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols
Alonso V Pacheco, Kanwaldeep Rasila, Sang-Joon Lee, et al.
Leukemia & Lymphoma
|
March 5, 2014
Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups
Edward Libby, David Garcia, Dulcinea Quintana, et al.
Cancer Chemotherapy and Pharmacology
|
August 7, 2008
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
Claire F Verschraegen, Keith Skubitz, Adil Daud, et al.
Translational Oncology
|
April 22, 2014
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
Julie Bauman, Monte Shaheen, Claire F Verschraegen, et al.
The Journal of Molecular Diagnostics : JMD
|
June 27, 2007
Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma
Lisa M Davis, Cole Harris, Lei Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer
Massimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Plos One
|
November 1, 2023
The inflammatory response of human pancreatic cancer samples compared to normal controls
Kathryn J Brayer, Joshua A Hanson, Shashank Cingam, et al.
Oncology Research
|
February 10, 2011
Tumor MET expression may not predict the risk of venous thromboembolism in cancer patients
Hamid Sayar, Jeffrey T Bunning, Therese J Bocklage, et al.
American Journal of Clinical Oncology
|
November 4, 2009
A phase I study of flavopiridol in combination with gemcitabine and irinotecan in patients with metastatic cancer
Houman M Fekrazad, Claire F Verschraegen, Melanie Royce, et al.
Plos One
|
March 18, 2016
Antioxidants Abrogate Alpha-Tocopherylquinone-Mediated Down-Regulation of the Androgen Receptor in Androgen-Responsive Prostate Cancer Cells
Alexandra M Fajardo, Debra A MacKenzie, Sarah L Olguin, et al.
Urologic Oncology
|
March 28, 2008
Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols
Alonso V Pacheco, Kanwaldeep Rasila, Sang-Joon Lee, et al.
Leukemia & Lymphoma
|
March 5, 2014
Disease-specific survival for patients with multiple myeloma: significant improvements over time in all age groups
Edward Libby, David Garcia, Dulcinea Quintana, et al.
Cancer Chemotherapy and Pharmacology
|
August 7, 2008
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors
Claire F Verschraegen, Keith Skubitz, Adil Daud, et al.
Translational Oncology
|
April 22, 2014
A Phase I Protocol of Hydralazine and Valproic Acid in Advanced, Previously Treated Solid Cancers
Julie Bauman, Monte Shaheen, Claire F Verschraegen, et al.
The Journal of Molecular Diagnostics : JMD
|
June 27, 2007
Amplification patterns of three genomic regions predict distant recurrence in breast carcinoma
Lisa M Davis, Cole Harris, Lei Tang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 11, 2010
Phase II, randomized trial to compare anastrozole combined with gefitinib or placebo in postmenopausal women with hormone receptor-positive metastatic breast cancer
Massimo Cristofanilli, Vicente Valero, Aroop Mangalik, et al.
Page
of 4